Latest Share Chat

REMOVE ADS

Oxford Biomedica Share News (OXB)

Oxford Biomedica Information

Share Price Information for Oxford Biomedica (OXB)

Share Price is delayed by 15 minutes

Get Live Data

604.00 4.00 (0.67%)

Bid:

600.00

Ask:

602.00

Spread: 2.00 (0.333%)

Market Cap: £730.89m

Last checked at -

Intraday Oxford Biomedica Share Chart

REMOVE ADS

Oxford Biomedica News

Oxford BioMedica Reports ProSavin Promise In Two-Year Study

LONDON (Dow Jones)--Biotechnology company Oxford BioMedica PLC (OXB.LN) Monday said two patients in a three-patient study of its experimental Parkinso...

Oxford BioMedica says Parkinson's drug 'promising'

Oxford BioMedica's ongoing Phase I/II trial of its ProSavin drug to treat Parkinson's disease has shown "sustained" improvements in patients. Follow-...

TechMARK movers: Ark seeks partners

Cancer treatments developer Ark Therapeutics has completed its strategic review and this has been received positively by the market. Ark intends to ...

TechMARK movers: NXT disappoints

Flat speaker technology developer NXT says revenues have been below expectations since the beginning of 2010. New product delays have not helped and...

Small caps round-up: 32Red, Alkane, Norseman...

Online casino operator 32Red enjoyed a "strong" recovery in the second half and said revenues increased 10% in January and February. Profit before ta...

Thursday tips round-up: Wetherspoon, Soco, Character

The economic backdrop remains tough but Wetherspoon's value-for-money offer and unmatched retail skills will ensure that it is among the winners. At 4...

Oxford boosted by EMA oprhan drug designation

Gene therapy company Oxford Biomedica said UshStat, its treatement for Usher syndrome 1B, has received orphan designation from the Committee for Orpha...

London close: Blue chips falter after recent strength

London closed lower as bumper profits at US investment bank Goldman Sachs failed to spark Wall Street, which has retreated from the 10,000 mark hit la...